A European Academic Pharmaceutical development institute

Author: Inactive user |

Updated on: 11 May 2021 |

Number of views: 690

We see with the Corona crisis that the vaccines are quite rapidly developped and tested.

But it are not those who did the work who get the reward.

The researchers are well payed but the loot goes to the shareholders.

The reason why this happens is obvious: European academic funding for pharmaceutical research is not going well:

Researchers have usually temporary projectbased contracts for low or moderate pay. So they can be easily pulled away by investors just by the promise of a stable carreerpath.

At the end we all lose in this: European taxpayers pay far too much for the vaccination and the money does not go to the researcher but to the shareholders.

This should change by starting a European pharmaceutical research institute where pharmaceutical researchers get a decent pay and careerpath. So that they don't run away to the industry.

It is not just about coronavaccins but also cancer treatment and rare disease treatment, where pricing is set to the market: what the goverments are willing to pay to get the patients treated.

Categories

To be able to add comments, you need to authenticate or register.

Comments

Inactive user | 11 May 2021

I voted also for the vaccines and drugs developed, researched and delivered to be registered under public domain, with no patents.

Julia Hadjikyriacou | 24 June 2021

I 100% agree.

Inactive user | 17 May 2021

There is an urgent need to increase public funding. This is not just the coronavirus pandemic. Only antibiotic-resistant bacteria are considered here, where more research would be urgently needed.

I would make the question of better funding for research, but not the question of patents. In addition to much-needed state funding and institutes, there is also research in the private sector. Where should private companies still be encouraged to carry out research if there would no longer be patents?

Julia Hadjikyriacou | 24 June 2021

My personal opinion is that pandemic vaccine research must be nationalised with zero profits. Or with very minimal profits at the very least. This hunger and greed by big pharmaceutical companies for billions in profits has led to the abuse of the Emergency Use Authorisation law. We are seeing re-purposed drugs that have been proved multiple times to stop the virus from replicating being supressed, deleted, censored and not being offered to the people because the vaccine corporations will lose their Emergency Use Authorisation. People are being allowed to simply suffer or die for the sake of milking the sales window that the EUA offers clinical trial vaccines. Let alone the unethical practice of using mRNA technology on masses of people that has never been tested on humans before. In my country EU member Cyprus, most people are not even informed of the clinical trial nature of the vaccine or the EU COVAX compensation scheme for vaccine damage. This is a horrific time in EU history that must never be allowed to be repeated ever again.

Inactive user | 24 June 2021

No need to nationalize and impose zero profits, it's enough to remove patents to create competition so that small pharmaceutical companies can produce medicine locally without the restrictions and obligations towards big corporate pharma.

No need to nationalize, but instead we can support a European Union wide public institution for development and production of vaccines, with public money. We don't need to eliminate the existent companies - not only that it's too radical and outside reality, it's not beneficial at all, to no one, not even consumers.